Selected regulations and guidance for drug studies as of April 1, 2004:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Philadelphia, PA
Clinical Research Resources
c2004
|
| Schriftenreihe: | Code of federal regulations: ICH guidelines
|
| Schlagworte: | |
| Beschreibung: | CFR Title 21, Food & Drugs: Index to Part 11, 50, 54, 56, 312, 314: 11. Electronic records; electronic signatures -- 50. Protection of human subjects -- 54. Financial disclosure by clinical investigators -- 56. Institutional review boards -- 312. Investigational new drug application -- 314. Applications for FDA approval to market a new drug -- Proposed Amendments: 312.32. IND safety report -- 312.64. Invesigator reports -- ICH guidelines (Step 5, US: E6. Good clinical practice: consolidated guidance -- E2A. Clinical safety data management: definitions and standards for expedited reporting -- E8. General considerations for clinical trials -- European directive on GCP 2001/20/EC -- Additional guidance: Guideline for monitoring of clinical investigations -- Selected drug development Wen sites -- PhRMA principles on conduct of clinical trials -- Compliance manual for FDA staff (#7348.810) |
| Beschreibung: | Getr. Zählung 19 cm |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV035038806 | ||
| 003 | DE-604 | ||
| 005 | 20081014 | ||
| 007 | t | ||
| 008 | 080904s2004 |||| 00||| eng d | ||
| 035 | |a (OCoLC)56044588 | ||
| 035 | |a (DE-599)BVBBV035038806 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-29 | ||
| 245 | 1 | 0 | |a Selected regulations and guidance for drug studies as of April 1, 2004 |c compiled, updated and formatted by Clinical Research Resources |
| 246 | 1 | 3 | |a Code of federal regulations: ICH guidelines |
| 246 | 1 | 3 | |a CFR Title 21 food & drugs revised as of April 1, 2004 |
| 246 | 1 | 3 | |a ICH guidelines (Step 5, US) |
| 246 | 1 | 3 | |a European directive on GCP 2001/20/EC |
| 264 | 1 | |a Philadelphia, PA |b Clinical Research Resources |c c2004 | |
| 300 | |a Getr. Zählung |c 19 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Code of federal regulations: ICH guidelines | |
| 500 | |a CFR Title 21, Food & Drugs: Index to Part 11, 50, 54, 56, 312, 314: 11. Electronic records; electronic signatures -- 50. Protection of human subjects -- 54. Financial disclosure by clinical investigators -- 56. Institutional review boards -- 312. Investigational new drug application -- 314. Applications for FDA approval to market a new drug -- Proposed Amendments: 312.32. IND safety report -- 312.64. Invesigator reports -- ICH guidelines (Step 5, US: E6. Good clinical practice: consolidated guidance -- E2A. Clinical safety data management: definitions and standards for expedited reporting -- E8. General considerations for clinical trials -- European directive on GCP 2001/20/EC -- Additional guidance: Guideline for monitoring of clinical investigations -- Selected drug development Wen sites -- PhRMA principles on conduct of clinical trials -- Compliance manual for FDA staff (#7348.810) | ||
| 650 | 4 | |a Clinical Trials / standards | |
| 650 | 4 | |a Drug Approval | |
| 650 | 4 | |a Drug, Investigational / standards | |
| 650 | 4 | |a Drug Evaluation / standards | |
| 650 | 4 | |a Human Experimentation / standards | |
| 650 | 4 | |a Clinical Trials / standards | |
| 650 | 4 | |a Clinical Trials |x standards | |
| 650 | 4 | |a Drug Approval | |
| 650 | 4 | |a Drug Evaluation / standards | |
| 650 | 4 | |a Drug Evaluation |x standards | |
| 650 | 4 | |a Drug, Investigational / standards | |
| 650 | 4 | |a Drug, Investigational |x standards | |
| 650 | 4 | |a Human Experimentation / standards | |
| 650 | 4 | |a Human Experimentation |x standards | |
| 650 | 0 | 7 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Zulassung |0 (DE-588)4127410-6 |2 gnd |9 rswk-swf |
| 655 | 2 | |a Guideline | |
| 655 | 2 | |a Legislation | |
| 689 | 0 | 0 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |D s |
| 689 | 0 | 1 | |a Zulassung |0 (DE-588)4127410-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016707662 | ||
Datensatz im Suchindex
| _version_ | 1804137972558200832 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| building | Verbundindex |
| bvnumber | BV035038806 |
| ctrlnum | (OCoLC)56044588 (DE-599)BVBBV035038806 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02851nam a2200553 c 4500</leader><controlfield tag="001">BV035038806</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20081014 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">080904s2004 |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)56044588</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV035038806</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Selected regulations and guidance for drug studies as of April 1, 2004</subfield><subfield code="c">compiled, updated and formatted by Clinical Research Resources</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Code of federal regulations: ICH guidelines</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">CFR Title 21 food & drugs revised as of April 1, 2004</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">ICH guidelines (Step 5, US)</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">European directive on GCP 2001/20/EC</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia, PA</subfield><subfield code="b">Clinical Research Resources</subfield><subfield code="c">c2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Getr. Zählung</subfield><subfield code="c">19 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Code of federal regulations: ICH guidelines</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">CFR Title 21, Food & Drugs: Index to Part 11, 50, 54, 56, 312, 314: 11. Electronic records; electronic signatures -- 50. Protection of human subjects -- 54. Financial disclosure by clinical investigators -- 56. Institutional review boards -- 312. Investigational new drug application -- 314. Applications for FDA approval to market a new drug -- Proposed Amendments: 312.32. IND safety report -- 312.64. Invesigator reports -- ICH guidelines (Step 5, US: E6. Good clinical practice: consolidated guidance -- E2A. Clinical safety data management: definitions and standards for expedited reporting -- E8. General considerations for clinical trials -- European directive on GCP 2001/20/EC -- Additional guidance: Guideline for monitoring of clinical investigations -- Selected drug development Wen sites -- PhRMA principles on conduct of clinical trials -- Compliance manual for FDA staff (#7348.810)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials / standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug, Investigational / standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation / standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human Experimentation / standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials / standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials</subfield><subfield code="x">standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation / standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation</subfield><subfield code="x">standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug, Investigational / standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug, Investigational</subfield><subfield code="x">standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human Experimentation / standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human Experimentation</subfield><subfield code="x">standards</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Guideline</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Legislation</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016707662</subfield></datafield></record></collection> |
| genre | Guideline Legislation |
| genre_facet | Guideline Legislation |
| id | DE-604.BV035038806 |
| illustrated | Not Illustrated |
| index_date | 2024-07-02T21:52:29Z |
| indexdate | 2024-07-09T21:20:47Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016707662 |
| oclc_num | 56044588 |
| open_access_boolean | |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | Getr. Zählung 19 cm |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | Clinical Research Resources |
| record_format | marc |
| series2 | Code of federal regulations: ICH guidelines |
| spelling | Selected regulations and guidance for drug studies as of April 1, 2004 compiled, updated and formatted by Clinical Research Resources Code of federal regulations: ICH guidelines CFR Title 21 food & drugs revised as of April 1, 2004 ICH guidelines (Step 5, US) European directive on GCP 2001/20/EC Philadelphia, PA Clinical Research Resources c2004 Getr. Zählung 19 cm txt rdacontent n rdamedia nc rdacarrier CFR Title 21, Food & Drugs: Index to Part 11, 50, 54, 56, 312, 314: 11. Electronic records; electronic signatures -- 50. Protection of human subjects -- 54. Financial disclosure by clinical investigators -- 56. Institutional review boards -- 312. Investigational new drug application -- 314. Applications for FDA approval to market a new drug -- Proposed Amendments: 312.32. IND safety report -- 312.64. Invesigator reports -- ICH guidelines (Step 5, US: E6. Good clinical practice: consolidated guidance -- E2A. Clinical safety data management: definitions and standards for expedited reporting -- E8. General considerations for clinical trials -- European directive on GCP 2001/20/EC -- Additional guidance: Guideline for monitoring of clinical investigations -- Selected drug development Wen sites -- PhRMA principles on conduct of clinical trials -- Compliance manual for FDA staff (#7348.810) Clinical Trials / standards Drug Approval Drug, Investigational / standards Drug Evaluation / standards Human Experimentation / standards Clinical Trials standards Drug Evaluation standards Drug, Investigational standards Human Experimentation standards Arzneimittelprüfung (DE-588)4128030-1 gnd rswk-swf Zulassung (DE-588)4127410-6 gnd rswk-swf Guideline Legislation Arzneimittelprüfung (DE-588)4128030-1 s Zulassung (DE-588)4127410-6 s DE-604 |
| spellingShingle | Selected regulations and guidance for drug studies as of April 1, 2004 Clinical Trials / standards Drug Approval Drug, Investigational / standards Drug Evaluation / standards Human Experimentation / standards Clinical Trials standards Drug Evaluation standards Drug, Investigational standards Human Experimentation standards Arzneimittelprüfung (DE-588)4128030-1 gnd Zulassung (DE-588)4127410-6 gnd |
| subject_GND | (DE-588)4128030-1 (DE-588)4127410-6 |
| title | Selected regulations and guidance for drug studies as of April 1, 2004 |
| title_alt | Code of federal regulations: ICH guidelines CFR Title 21 food & drugs revised as of April 1, 2004 ICH guidelines (Step 5, US) European directive on GCP 2001/20/EC |
| title_auth | Selected regulations and guidance for drug studies as of April 1, 2004 |
| title_exact_search | Selected regulations and guidance for drug studies as of April 1, 2004 |
| title_exact_search_txtP | Selected regulations and guidance for drug studies as of April 1, 2004 |
| title_full | Selected regulations and guidance for drug studies as of April 1, 2004 compiled, updated and formatted by Clinical Research Resources |
| title_fullStr | Selected regulations and guidance for drug studies as of April 1, 2004 compiled, updated and formatted by Clinical Research Resources |
| title_full_unstemmed | Selected regulations and guidance for drug studies as of April 1, 2004 compiled, updated and formatted by Clinical Research Resources |
| title_short | Selected regulations and guidance for drug studies as of April 1, 2004 |
| title_sort | selected regulations and guidance for drug studies as of april 1 2004 |
| topic | Clinical Trials / standards Drug Approval Drug, Investigational / standards Drug Evaluation / standards Human Experimentation / standards Clinical Trials standards Drug Evaluation standards Drug, Investigational standards Human Experimentation standards Arzneimittelprüfung (DE-588)4128030-1 gnd Zulassung (DE-588)4127410-6 gnd |
| topic_facet | Clinical Trials / standards Drug Approval Drug, Investigational / standards Drug Evaluation / standards Human Experimentation / standards Clinical Trials standards Drug Evaluation standards Drug, Investigational standards Human Experimentation standards Arzneimittelprüfung Zulassung Guideline Legislation |